, Tracking Stock Market Picks
Enter Symbol:
Mead Johnson Nutrition Company (MJN) [hlAlert]

up 2.59 %

Mead Johnson Nutrition Company (MJN) upgraded to Outperform by Wells Fargo

Posted on: Monday,  Feb 10, 2014  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Mead Johnson Nutrition Company (NYSE: MJN) on 02/10/2014, when the stock price was $76.39.
Since then, Mead Johnson Nutrition Company has gained 2.59% as of 01/08/2016's recent price of $78.37.
If you would have followed this Wells Fargo's recommendation on MJN, you would have gained 2.59% of your investment in 697 days.

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company?s Enfa family of brands, including Enfamil infant formula, is a global brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. Mead Johnson markets its portfolio of more than 70 products to mothers, health care professionals and retailers in more than 50 countries in North America, Europe, Asia and Latin America. The Company?s two segments include North America/Europe and Asia/Latin America, which comprised 52.4% and 47.6%, respectively, of its net sales during the year ended December 31, 2007. The two principal product categories, in which the Company operates, include infant formula and children?s nutrition. In 2008, Mead Johnson launched Nutramigen AA, an amino acid infant formula for infants with severe protein allergies.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/10/2014 8:25 AM Buy
as of 10/17/2014
1 Week up  6.46 %
1 Month up  2.66 %
3 Months up  9.04 %
1 YTD up  31.20 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/3/2013 8:25 AM Hold
10/2/2012 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy